AVGO vs BCI Stock Comparison
BCI currently leads AVGO in this stock comparison, with AIQ scores of 56 vs 55. The clearest difference is value, while AVGO has the stronger risk resilience profile.
What is the main difference between AVGO and BCI?
BCI leads the current stock comparison as abrdn Bloomberg All Commodity Strategy K-1 Free ETF, with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI leads
BCI leads by 1 AIQ points, primarily on Value.
Fragile: 1 of 4 evidence groups support BCI, and its current signal state is conflicted.
Broadcom Inc.
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
The Algovestiq AIQ Score currently favors BCI over AVGO, 56 versus 55 as of Nov 18, 2026. BCI's advantage is driven primarily by stronger value, while AVGO holds the stronger risk resilience profile. BCI also shows the weaker technical structure relative to its 50-day moving average. 1 of 4 covered evidence groups favor BCI today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. BCI lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
Compare Broadcom Inc. and abrdn Bloomberg All Commodity Strategy K-1 Free ETF across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and BCI against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value48 vs 88BCI +40
- Risk Resilience48 vs 37AVGO +11
- Momentum49 vs 41AVGO +8
- Quality69 vs 63AVGO +6
1 of 4 evidence groups favor BCI. BCI’s edge is concentrated in value; AVGO keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Value +2
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- RSI Oversold — bullish, momentum, short horizon
BCI's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and BCI both carry a full feed there.
The central trade-off
BCI (abrdn Bloomberg All Commodity Strategy K-1 Free ETF): the stronger current systematic profile, led by value.
AVGO (Broadcom Inc.): the counter-case, on risk resilience, momentum, quality — but at materially higher volatility, 70% against 12.3%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BCIBCI on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
BCIBCI on the peer-relative Value factor, by 40 points.
Momentum
AVGOAVGO on the Momentum factor, by 8 points.
Lower downside
AVGOAVGO on Risk Resilience, by 11 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AVGO | BCI | Note |
|---|---|---|---|
| Implied upside to target | +45.5% | — | Level |
| Target dispersion | +48.5% | — | Lower is tighter analyst agreement |
| Consensus | Buy | — | Context, not a primary driver |
| Analysts covering | 51 | — | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
1 of 4 covered evidence groups favor BCI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 55 vs 56 |
| Fundamentals | Not covered | Not covered |
| Valuation | BCI | Value 48 vs 88 |
| Technicals | AVGO | Price vs 50-day 2.5% vs -9.1%; vs 200-day -5.6% vs 0.9% |
| Risk Resilience | AVGO | Risk Resilience 48 vs 37 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and BCI and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 1 of 4 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCI.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18BCI lead: Stable — the AIQ differential has held near 1 points over 30 sessions.
- Today
- BCI +1
- 55 vs 56
- 7 sessions ago
- BCI +3
- 53 vs 56
- 30 sessions ago
- BCI +2
- 54 vs 56
- 90 sessions ago
- AVGO +4
- 57 vs 53
The lead changed hands 2 times in this window, most recently on Oct 14 when BCI moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only AVGO
- Death Cross Active — bearish, trend, long horizon (6.38%)
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
- Accumulation Pattern — bullish, volume, medium horizon (1.18x)
- Beta Spike Warning — bearish, risk_regime, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
3 bullish / 1 bearish / 2 neutral, conflicted
Only BCI
- Golden Cross Active — bullish, trend, long horizon (6.73%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Contraction - Coiling — neutral, volatility, short horizon (1.23%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold — bullish, momentum, short horizon
BCI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +3.64%, AIQ +1 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.08%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Value gap — currently 40 points behind, the largest single contributor to BCI's edge.
- 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BCI's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | AVGO | BCI |
|---|---|---|
| Revenue growth (YoY) | 33.4% | — |
| EPS growth (YoY) | 40.3% | — |
| Gross margin | 68.8% | — |
| Operating margin | 48% | — |
| Return on equity (TTM) | 13.1% | — |
| Debt to equity | 0.6 | — |
Performance
BCI leads 4 of 6 windows| Metric | AVGO | BCI |
|---|---|---|
| 1 week (5 sessions) | 18.2% | -0.6% |
| 1 month (20 sessions) | 5.6% | -7.3% |
| 3 months (63 sessions) | -11.6% | -1.8% |
| 6 months (126 sessions) | -18.4% | -3.4% |
| Year to date | 0.3% | 25.4% |
| 1 year (252 sessions) | -2.3% | 8% |
Technicals
AVGO has the stronger structure| Metric | AVGO | BCI |
|---|---|---|
| RSI (14) | 53.2 | 29.3 |
| ADX (14) | 23 | 35.5 |
| Price vs 50-day | 2.5% | -9.1% |
| Price vs 200-day | -5.6% | 0.9% |
| Volatility (1M, annualized) | 70% | 12.3% |
Risk
AVGO is the more resilient| Metric | AVGO | BCI |
|---|---|---|
| Beta | 2.21 | -0.21 |
| Sharpe ratio | 0.21 | 0.3 |
| Sortino ratio | 0.29 | 0.36 |
| Max drawdown | -39.5% | -16.3% |
| Current drawdown | -27.9% | -8.6% |
| Annualized volatility | 48.6% | 22.6% |
| Value at risk (95%) | -4.6% | -1.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or BCI?
On the Algovestiq AIQ Score, BCI is the stronger of the two as of Nov 18, 2026, scoring 56 against AVGO's 55. The edge comes from value. AVGO is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or BCI the better buy right now?
BCI carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 1 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor BCI over AVGO?
The composite weights Quality, Value, Momentum and Risk Resilience. BCI leads Value by 40 points; AVGO leads Risk Resilience by 11 points; AVGO leads Momentum by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or BCI?
Analyst price targets imply +45.5% upside for AVGO and not covered for BCI. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or BCI?
BCI is the better-valued of the two on the peer-relative Value factor. BCI on the peer-relative Value factor, by 40 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or BCI?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or BCI?
AVGO on the Momentum factor, by 8 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or BCI?
AVGO is the more resilient of the two, so the other name carries the higher downside risk. AVGO on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than BCI?
Margin data is not comparable for both names in the current snapshot.
Is BCI's lead over AVGO getting stronger or weaker?
BCI lead: Stable — the AIQ differential has held near 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands 2 times in that window, most recently on 2026-10-14, when BCI moved ahead of AVGO.
What would change the AVGO vs BCI verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Value gap — currently 40 points behind, the largest single contributor to BCI's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; BCI's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AVGO and BCI?
AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. BCI: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On BCI it is Golden Cross Active (bullish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.